| Overview |
| bsm-62084r |
| Apolipoprotein CI/APOC1 Recombinant Antibody |
| WB, IHC-P, IHC-F, IP, IF, Flow-Cyt, ICC/IF |
| Human |
| Specifications |
| Unconjugated |
| Rabbit |
| KLH conjugated synthetic peptide derived from human Apolipoprotein C1 |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target |
| 341 |
| P02654 |
| APO C1; Apo CI; APOC 1; ApoC I; APOC1; APOC1B; ApolipoproteinCI. |
| Inhibitor of lipoprotein binding to the low density lipoprotein (LDL) receptor, LDL receptor-related protein, and very low density lipoprotein (VLDL) receptor. |
| Application Dilution |
| WB |
1:300-5000 |
| IHC-P |
FCM1:20-100 |
| IHC-F |
IHC-P1:200-400 |
| IP |
IHC-F1:100-500 |
| IF |
ICC1:50-200 |
| Flow-Cyt |
IP1-2ug |
| ICC/IF |
IF |
Powered by Bioz